white
woman
present
hospit
acut
short
breath
flight
back
england
holiday
turkey
deni
product
cough
hemoptysi
chest
calf
pain
asthmat
symptom
improv
repeat
administr
salbutamol
inhal
flight
past
medic
histori
nasal
polyp
requir
surgic
intervent
year
previous
one
month
previous
treat
cours
amoxicillin
chronic
otiti
media
await
ear
nose
throat
ent
specialti
appoint
also
develop
swollen
tender
metacarpophalang
ankl
joint
found
posit
rheumatoid
factor
symptom
subsequ
improv
short
cours
prednisolon
felt
well
enough
go
holiday
work
secretari
law
firm
never
smoke
longterm
partner
drank
bottl
wine
week
children
never
pregnant
present
temperatur
c
f
respiratori
rate
breath
per
minut
heart
rate
beat
per
minut
blood
pressur
mmhg
requir
oxygen
suppli
lmin
maintain
oxygen
satur
auscult
chest
reveal
bilater
crackl
urin
dipstick
test
reveal
blood
protein
neg
pregnanc
remaind
physic
examin
unremark
initi
investig
result
shown
tabl
thorax
comput
tomographi
figur
demonstr
extens
bilater
patchi
air
space
infiltr
groundglass
chang
evid
embol
diseas
given
histori
elev
creactiv
protein
anemia
diffus
alveolar
infiltr
diagnosi
pulmonari
hemorrhag
secondari
autoimmun
vasculit
process
superimpos
chest
infect
made
transfus
unit
blood
treat
intraven
coamoxiclav
oral
doxycyclin
mg
intraven
methylprednisolon
given
day
convert
oral
prednisolon
mg
per
day
result
viral
serolog
immunolog
test
avail
day
admiss
tabl
repeat
sampl
remain
serolog
neg
specif
autoimmun
process
lung
spirometri
day
demonstr
dlcoc
correct
transfer
factor
kco
transfer
coeffici
predict
respect
given
complex
case
lung
biopsi
undertaken
day
figur
demonstr
foci
organ
pneumonia
evid
pulmonari
hemorrhag
activ
vascul
patient
improv
cours
week
discharg
plan
taper
dose
prednisolon
seen
rheumatolog
clinic
week
post
discharg
found
haematoproteinuria
creatinin
mmoll
discharg
mmoll
enzymelink
immunosorb
assay
elisa
immunoglobulin
g
igg
antineutrophil
cytoplasm
antibodi
anca
neg
howev
period
immunolog
laboratori
note
discrep
anca
result
differ
patient
second
patient
transfer
anoth
hospit
renal
unit
posit
anca
posit
igg
antiproteinas
antibodi
howev
measur
igg
antiproteinas
antibodi
neg
local
method
store
blood
sampl
patient
analyz
altern
method
indirect
immunofluoresc
iif
screen
method
show
cytoplasm
anca
stain
pattern
howev
igg
antiproteinas
level
uml
refer
rang
uml
local
method
uml
altern
method
given
renal
impair
activ
urinari
sediment
patient
underw
renal
biopsi
figur
show
pauciimmun
crescent
glomerulonephr
consist
vascul
granulomatosi
polyangi
formerli
known
wegen
granulomatosi
one
ancaassoci
vasculitid
aav
typic
present
upper
lower
respiratori
tract
granuloma
pauciimmun
glomerulonephr
incid
preval
granulomatosi
polyangi
uk
estim
case
per
million
per
year
respect
present
commonli
year
age
maletofemal
ratio
sinc
anca
use
serolog
marker
aid
diagnosi
aav
laboratori
worldwid
use
iif
screen
anca
techniqu
mix
patient
serum
neutrophil
presenc
pattern
bind
anca
reveal
subsequ
fluoresc
stain
cytoplasm
anca
stain
pattern
typic
associ
igg
antibodi
proteinas
perinuclear
p
pattern
myeloperoxidas
mpo
specif
iif
high
howev
posit
predict
valu
signific
variabl
result
occur
due
differ
slide
prepar
oper
experi
coexist
inflammatori
condit
also
caus
high
frequenc
fals
posit
result
recommend
initi
iif
screen
anca
confirm
solid
phase
assay
enzymelink
immunosorb
assay
elisa
howev
clinic
signific
epitop
target
antigen
mpo
poorli
expos
elisa
microtit
well
fals
low
concentr
report
newer
assay
use
antibodi
bind
distinct
nonfunct
epitop
antigen
anchor
captur
molecul
support
medium
allow
increas
assay
specif
sensit
howev
variat
antigen
prepar
techniqu
lack
intern
refer
materi
mean
still
signific
variat
anca
result
everi
patient
also
make
slightli
differ
igg
antibodi
particular
antigen
epitop
antigen
patient
respond
may
also
chang
cours
diseas
treatment
studi
compar
differ
elisa
techniqu
healthi
control
patient
known
granulomatosi
polyangi
show
high
specif
method
sensit
vari
captur
elisa
anchor
elisa
intern
refer
prepar
igg
antimpo
prepar
igg
current
final
evalu
full
impact
introduct
take
year
compon
elisabas
techniqu
also
need
harmon
detail
definit
antigen
epitop
use
nevertheless
discrep
seen
assay
pose
problem
aid
diagnosi
granulomatosi
polyangi
particularli
patient
complex
atyp
present
patient
categor
gener
system
vascul
commenc
cours
remiss
induct
rituximab
infus
prednisolon
accord
european
vascul
societi
euva
vascul
protocol
twelv
month
initi
present
patient
episod
pulmonari
hemorrhag
creatinin
mmoll
estim
glomerular
filtrat
rate
mlminbodi
surfac
area
prednisolon
dose
subsequ
taper
introduct
mycophenol
mofetil
g
per
day
maintain
remiss
case
highlight
potenti
pitfal
anca
test
diagnosi
patient
granulomatosi
polyangi
despit
improv
elisa
assay
sensit
specif
high
intermethod
variat
exist
import
clinician
appreci
limit
test
singl
assay
show
clinic
specif
sensit
case
highlight
need
good
commun
laboratori
result
surpris
inconsist
clinic
pictur
diagnosi
aav
clinic
laboratori
one
latter
point
reflect
american
colleg
rheumatolog
criteria
use
identifi
granulomatosi
polyangi
patient
clinic
trial
includ
anca
result
american
journal
medicin
vol
march
